Position in NVO
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$3,020
+$705 QoQ
Shares Held
63
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#1,301
of 1,348 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Fairman Group, LLC holds $485,757 across 8 Drug Manufacturers - General names. NVO ranks #6 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
986 | $248,117 | |
| 2 | MRK |
Merck & Co., Inc.
|
669 | $85,966 | |
| 3 | PFE |
Pfizer Inc
|
3,288 | $79,175 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
718 | $41,371 | |
| 5 | JNJ |
Johnson & Johnson
|
104 | $26,412 | |
| 6 | NVO |
Novo Nordisk A S
This page
|
63 | $3,020 | |
| 7 | GSK |
GSK plc
|
20 | $1,048 | |
| 8 | BIIB |
Biogen Inc.
|
3 | $648 |
All Filings in NVO
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,020 | 63 | Shares | Sole | 2026-08-04 | |
| 2026-03-31 | $2,315 | 63 | Shares | Sole | 2026-04-23 | |
| 2025-12-31 | $3,205 | 63 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $3,495 | 63 | Shares | Sole | 2025-10-31 | |
| No filing history on record for this holder in this stock. | ||||||